Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Mometasone for Vasoocclusive Events in Sickle Cell Disease
NCT02061202Phase 2Completed
- Start
- Mar 2014
- Primary completion
- Nov 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mometasone in sickle cell disease (SCD). Started Mar 2014; status: completed.
02
Drugs
mometasone
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02061202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02061202.